In US and Canada Call Toll Free: (877) 597-9236
Everywhere Else Call: (760) 431-6300

Nucleic Acid Purification Market 2016: New Life Science Dashboard™ from Percepta observes decreased number of end-users but projects unit growth in the dynamic $1 Billion market in North America and Europe

percepta

11th Jul, 2016

News

0

Qiagen’s dominant position has eroded in seven of the fifteen segments surveyed, resulting in other suppliers share gain

Carlsbad, Calif. – On June 30th Percepta Associates released its 2016 Nucleic Acid Purification, Series 5 Life Science Dashboard™ report which draws comparisons to key market indicator data reported in Percepta’s 2013 Series 4 Dashboard report.   This updated dashboard reveals a significant…

read more >

Top Bioinformatics Concerns for NGS Researchers

percepta

10th Oct, 2013

Blog, Polls

0

What are the top bioinformatics concerns for researchers that perform next-generation sequencing? We wanted to understand their “top of mind” concerns and not prompt users with a list of potential answers from which to choose.  So, we asked over 400 scientists in government, private, commercial and academic labs in the United States, all involved in performing next generation sequencing,…

read more >

NGS in the Clinic: NIH Awards $8M Grant for Pre-Conception Whole Genome Sequencing Study

percepta

26th Jul, 2013

Articles, Blog

0

The Kaiser Permanente Center for Health Research was awarded $8.1 million from the National Institutes of Health (NIH) to conduct a novel clinical trial using whole genome sequencing to test women and their partners, before they actually conceive, for mutations that could cause rare, but serious diseases in their offspring.

The project is part of the Clinical Sequencing Exploratory Research…

read more >

Copyright © 2021 Percepta Associates Inc. All rights reserved. Terms & Conditions.